This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by d’Amati, G. Articles by Celi, F. S. Search for Related Content PubMed PubMed Citation Articles by d’Amati, G. Articles by Celi, F. S.

Increased Expression of Thyroid Hormone Receptor Isoforms in End-Stage Human Congestive Heart Failure¹

Dipartimento di Medicina Sperimentale e Patologia (G.d.’A., C.R.T.d.G., D.M., D.P., L.P.-P., P.G., F.S.), and Istituto di Chirurgia del Cuore e Grossi Vasi (F.M.), Università degli studi di Roma "La Sapienza," Rome 00161, Italy

Address all correspondence and requests for reprints to: Francesco Saverio Celi, M.D., I Cattedra di Endocrinologia, Dipartimento di Medicina Sperimentale e Patologia, Policlinico Umberto I, Viale Regina Elena, 324, 00161 Roma, Italy. E-mail: francescosaverio.celi{at}uniroma1.it

Thyroid hormone plays an important role on myocardial development and function. The local effects of thyroid hormone are mediated by the receptor isoforms ultimately driving the expression of cardiac-specific genes. Although overt and subclinical thyroid dysfunction causes well-known changes in the cardiovascular system, little is known about local thyroid hormone action in normal and failing human myocardium. With a newly developed multiplex competitive RT-PCR method, we evaluated the expression of thyroid hormone receptor (TR) isoforms -1, -2, and ß-1 in normal human hearts and in end-stage congestive heart failure. A statistically significant difference in the expression of all three TR isoforms was observed among samples from normal subjects, ischemic heart disease (IHD), and dilated cardiomyopathy (DCM). In DCM, compared with normal, the studied TR isoforms were significantly increased. In IHD, the increased expression was found significant only for -1 and -2 isoforms. No differences were observed between the pathologic groups. In conclusion, a coordinated increment in the expression of the TR isoforms was observed in both DCM and IHD by multiplex competitive RT-PCR. The observed changes could represent a compensatory mechanism to myocardial failure or to locally altered thyroid hormone action.

This article has been cited by other articles:

				C. Pantos, A. Dritsas, I. Mourouzis, A. Dimopoulos, G. Karatasakis, G. Athanassopoulos, S. Mavrogeni, A. Manginas, and D. V Cokkinos Thyroid hormone is a critical determinant of myocardial performance in patients with heart failure: potential therapeutic implications Eur. J. Endocrinol., October 1, 2007; 157(4): 515 - 520. [Abstract] [Full Text] [PDF]

				C. Pantos, I. Mourouzis, C. Xinaris, A. D Kokkinos, K. Markakis, A. Dimopoulos, M. Panagiotou, T. Saranteas, G. Kostopanagiotou, and D. V Cokkinos Time-dependent changes in the expression of thyroid hormone receptor {alpha}1 in the myocardium after acute myocardial infarction: possible implications in cardiac remodelling Eur. J. Endocrinol., April 1, 2007; 156(4): 415 - 424. [Abstract] [Full Text] [PDF]

				A. Kenessey, E. A. Sullivan, and K. Ojamaa Nuclear localization of protein kinase C-{alpha} induces thyroid hormone receptor-{alpha}1 expression in the cardiomyocyte Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H381 - H389. [Abstract] [Full Text] [PDF]

				A. Kenessey and K. Ojamaa Ligand-mediated decrease of thyroid hormone receptor-{alpha}1 in cardiomyocytes by proteosome-dependent degradation and altered mRNA stability Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H813 - H821. [Abstract] [Full Text] [PDF]

				T. Mitin, L. L. von Moltke, M. H. Court, and D. J. Greenblatt LEVOTHYROXINE UP-REGULATES P-GLYCOPROTEIN INDEPENDENT OF THE PREGNANE X RECEPTOR Drug Metab. Dispos., August 1, 2004; 32(8): 779 - 782. [Abstract] [Full Text] [PDF]

				K. Feingold, M. S. Kim, J. Shigenaga, A. Moser, and C. Grunfeld Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E201 - E207. [Abstract] [Full Text] [PDF]

				K. Kinugawa, C. S. Long, and M. R. Bristow Expression of TR Isoforms in Failing Human Heart J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 5089 - 5089. [Full Text] [PDF]

				G. d'Amati and F. S. Celi Authors' Response: Expression of TR Isoforms in Failing Human Heart J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 5089 - 5090. [Full Text] [PDF]

				M. A. Sussman When the Thyroid Speaks, the Heart Listens Circ. Res., September 28, 2001; 89(7): 557 - 559. [Full Text] [PDF]